Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling

Shock

Volumn 14, Issue 3, 2000, Pages 265-270

  Ciesla, David J ^a   Moore, Ernest E ^a   Gonzalez, Ricardo J ^a   Biffl, Walter L ^a   Silliman, Christopher C ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Attenuation; Hypertonic saline (HTS); Neutrophil (PMN); Platelet activating factor (PAF)

Indexed keywords

CD18 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; SODIUM CHLORIDE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CELL CULTURE; DRUG EFFECT; HUMAN; METABOLISM; NEUTROPHIL; SIGNAL TRANSDUCTION;

ANTIGENS, CD18; CELLS, CULTURED; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OXYGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET ACTIVATING FACTOR; SALINE SOLUTION, HYPERTONIC; SUPEROXIDES;

EID: 0034278284     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200014030-00004     Document Type: Article

References (27)

1. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320:365-376, 1989.
2. Partrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC: Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz 4:194-210, 1996.
3. Gay JC: Priming of neutrophil oxidative responses by platelet-activating factor. J Lipid Media 2(Suppl)S161-175, 1990.
4. Botha AJ, Moore FA, Moore EE, Peterson VM, Silliman CC, Goode AW: Sequential systemic platelet-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. Br J Surg 83:1407-1412, 1996.
5. Kim FJ, Moore EE, Moore FA, Biffl WL, Fontes B, Banerjee A: Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res 58:636-640, 1995.
6. Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC: Reduced PAF-acetylhydrolase activity is associated with postinjury multiple organ failure. Shock 7:170-174, 1997.
7. Partrick DA, Moore EE, Moore FA, Barnett CC, Silliman CC: Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils. J Trauma 43:297-302, 1997.
8. Nick JA, Avdi NJ, Young SK, Knall C, Gerwins P, Johnson GL, Worthen GS: Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and fMLP. J Clin Invest 99:975-986, 1997.
9. Partrick DA, Moore EE, Offner PJ, Meldrum DR, Tamura DY, Johnson JL, Silliman CC; Maximal human ncutrophil priming for superoxide production and elastase release requires p38 mitogen-activated protein kinase activation. Arch Surg 135:219-225, 2000.
10. Rizoli SB, Kapus A, Parodo J, Rotstein OD: Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition. J Trauma 46:794-798, 1999.
11. Junger WG, Hoyt DB, Davis RE, Herdon-Remelius C, Namiki S, Junger H, Loomis W, Altman A: Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest 101:2768-2779, 1998.
12. Mattox KL, Maningas PA, Moore EE, Mateer JR, Marx JA, Aprahamian C, Burch JM, and Pepe PE: Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg 213:482-491, 1991.
13. Ciesla DJ, Moore EE, Zallen G, Biffl WL, Silliman CC: Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. J Trauma 48:388-395, 2000.
14. Moore FA, Moore EE: Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 75:257-277, 1995.
15. Botha AJ, Moore FA, Moore EE, Fontes B, Banerjee A, Peterson VM: Postinjury neutrophil priming and activation states: therapeutic challenges. Shock 3:157-166, 1995.
16. Vassar MJ, Perry CA, Gannaway WL, Holcroft JW: 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg 126:1065-1072, 1991.
17. Younes RN, Aun F, Accioly CQ, Casale LP, Szajnbok I, Birolini D: Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery 111:380-385, 1992.
18. Kramer GC, Perron PR, Lindsey DC, Ho HS, Gunther RA, Boyle WA, Holcroft JW: Small-volume resuscitation with hypertonic saline dextran solution. Surgery 100:239-247, 1986.
19. Coimbra R, Hoyt DB, Junger WG, Angle N, Wolf P, Loomis W, Evers MF: Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma 42:602-606; discussion 606-607, 1997.
20. Angle N, Hoyt DB, Coimbra R, Liu F, Herdon-Remelius C, Loomis W, Junger WG: Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 9:164-170, 1998.
21. Corso CO, Okamoto S, Ruttinger D, Messmer K: Hypertonic saline dextran attenuates leukocyte accumulation in the liver after hemorrhagic shock and resuscitation. J Trauma 46:417-423, 1999.
22. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ: Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 80:10-17, 1993.
23. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD: Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 161:6288-6296, 1998.
24. Gay JC, Beckman JK, Brash AR, Oates JA, Lukens JN: Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4. Blood 64:780-785, 1984.
25. Schnyder B, Meunier PC, Car BD: Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus. Biochem J 331:489-495, 1998.
26. + exchanger activation during shrinkage of human neutrophils. J Biol Chem 272:17303-17311, 1997.
27. Rizoli SB, Rotstein OD, Kapus A: Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J Biol Chem 274:22072-22080, 1999.